NCT06342206

Brief Summary

Cerebral infarction is the second cause of death and the third cause of disability. More than 13.7 million patients worldwide are diagnosed with stroke every year, and the number of deaths is 5.5 million, of which ischemic stroke is the major type, accounting for 87%. Sequelae of stroke are problems that require long-term medical care. If we can intervene and assist with Traditional Chinese Medicine (TCM) at early stage, it will be a great boon for patients. In clinical practice, TCM collects data as the basis for diagnosis through the four diagnostic methods-look, listen, question, and feel the pulse. Among these, tongue diagnosis and pulse diagnosis belong to the categories of look and feel the pulse. At present, the objective examination instruments of TCM developed are mainly tongue diagnostic instruments and pulse diagnostic instruments. Therefore, we hope to utilize tongue and pulse diagnoses as the main reference to analyze the changes in ischemic stroke stages. The data of this study are collected from China Medical University Hospital and YuanRung Hospital-for further statistical analysis. Ischemic stroke patients (ICD-10: I63) who were hospitalized within 1 week from the date of diagnosis were eligible to join this research project. Tongue and pulse examinations were collected once per week within 1 month. A total of 4 tongue-pulse examinations were collected in each case, which were categorized into acute stage (24 hours to 1 week), subacute stage (1 to 3 weeks) and chronic stage (more than 3 weeks). \[30\] This research is to study the changes of tongue and pulse diagnoses in acute, subacute and chronic stages among ischemic patients who receive TCM diagnosis and treatment. Through utilizing objective evaluation of Chinese and Western medical examination instruments, we hope to establish clear diagnostic standards for TCM syndrome types, so as to evaluate the efficacy of clinical diagnosis and treatment. The goal is to improve the quality of TCM care and to provide Chinese and Western integrated treatment for stroke patients in the future. This research can also serve as a reference for related TCM research and development.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 8, 2022

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2025

Completed
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

March 26, 2024

Last Update Submit

March 27, 2025

Conditions

Keywords

stage of stroke, tongue diagnosis, pulse diagnosis

Outcome Measures

Primary Outcomes (1)

  • Differences between tongue diagnosis and pulse diagnosis in acute and chronic stroke patients

    To compare the differences between tongue and pulse diagnosis in acute, subacute and chronic phases of stroke patients using statistical methods.

    Beginning September 2022 through October 2024

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

stroke patients in acute phase within 1 week will be included, and continues to collect their data in 2\~3 Weeks and 4 week.

You may qualify if:

  • Patients older than 40 years of age, who acted in concert with the complete examination and answered the questionnaire.
  • Participants were diagnosed as ischemic stroke (ICD-10:I63) by neurologist, and were approved by head CT or MRI examination.
  • Those with a stable vital sign after being examined by an internal medicine specialist
  • Those who experience a cerebral vascular accident within 10 days of the consultation
  • Signing the agreement document to join the research program

You may not qualify if:

  • Those with an unstable vital sign
  • Patients who were unable to protrude their tongue or the protruding length was insufficient
  • Those at risk of jaw dislocation
  • Those with an arteriovenous shunt or fistula
  • Those who experience seizures
  • Those with poor cognition and communication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

YuanRung Hospital

Changhua, 510, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

photography

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Lun-Chien Lo, profession

CONTACT

Yung-Sheng Huang, research assistant

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2024

First Posted

April 2, 2024

Study Start

September 8, 2022

Primary Completion

September 7, 2024

Study Completion

March 27, 2025

Last Updated

April 2, 2025

Record last verified: 2025-03

Locations